Everand Logo

Welcome to Everand!

  • NPR

    Cancer Drug That Might Slow Parkinson's, Alzheimer's Headed For Bigger Tests

    In a preliminary study, the cancer drug nilotinib seemed to help patients with Parkinson's and dementia. Now two larger and more rigorous studies of the drug are under way.
    by Jon Hamilton Mar 15, 2017 3 minutes
    A colored magnetic resonance imaging (MRI) scans of the brain of a 76-year-old patient with dementia shows the brain has atrophied and the dark brown fluid-filled spaces have become enlarged.

    Scientists are hoping that a single drug can treat two devastating brain diseases: Parkinson's and Alzheimer's.

    The drug is nilotinib, which is approved to treat a form of leukemia.

    In late 2015, researchers at Georgetown University Medical Center that small doses of the drug appeared to help a handful of people with Parkinson's disease and a related form of dementia. They'd tried the unlikely treatment because they knew nilotinib triggered cells to get

    You’re reading a preview, subscribe to read more.

    More from NPR

    NPR2 min readCrime & Violence
    Guatemalan AG Raids Save The Children Office Over A Migrant Children Rights Complaint
    Prosecutor Rafael Curruchiche said that the complaint filed by an unidentified foreigner had raised serious concerns because it involved allegations of abuse of children.
    NPR3 min readAmerican Government
    Trump's Immunity Arguments And The Experiences Of The Justices Who Might Support It
    Five of the six conservatives spent much of their lives in the Beltway, working in the White House and Justice Department, seeing their administrations as targets of unfair harassment by Democrats.
    NPR2 min readCrime & Violence
    Harvey Weinstein's 2020 Sex Crimes Conviction In New York Overturned
    The New York State Court of Appeals ruled Thursday that the former movie mogul had not received a fair trial in 2020 that led to a 23-year sentence, and ordered a new trial.

    Related Books & Audiobooks